215 related articles for article (PubMed ID: 16277548)
1. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy.
Brown P; Ki M; Foxman B
Pharmacoeconomics; 2005; 23(11):1123-42. PubMed ID: 16277548
[TBL] [Abstract][Full Text] [Related]
2. Descriptive Epidemiology of Acute Pyelonephritis in Korea, 2010-2014: Population-based Study.
Kim B; Myung R; Kim J; Lee MJ; Pai H
J Korean Med Sci; 2018 Dec; 33(49):e310. PubMed ID: 30505253
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
4. Acute pyelonephritis and associated complications during pregnancy in 2006 in US hospitals.
Jolley JA; Kim S; Wing DA
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2494-8. PubMed ID: 22725624
[TBL] [Abstract][Full Text] [Related]
5. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Chang UI; Kim HW; Wie SH
Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
[TBL] [Abstract][Full Text] [Related]
6. The effects of an institutional care map on the admission rates and medical costs in women with acute pyelonephritis.
Kim K; Lee CC; Rhee JE; Suh GJ; Lee HJ; Kim HB; Singer AJ
Acad Emerg Med; 2008 Apr; 15(4):319-23. PubMed ID: 18370984
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
8. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
10. [Acute complicated and uncomplicated pyelonephritis in the emergency department: process-of-care indicators and outcomes].
Delgado Vicente M; Lecaroz Agara MC; Barrios Andrés JL; Canut Blasco A
Emergencias; 2017 Feb; 29(1):27-32. PubMed ID: 28825265
[TBL] [Abstract][Full Text] [Related]
11. Incidence, admission rates, and economic burden of pediatric emergency department visits for urinary tract infection: data from the nationwide emergency department sample, 2006 to 2011.
Sood A; Penna FJ; Eleswarapu S; Pucheril D; Weaver J; Abd-El-Barr AE; Wagner JC; Lakshmanan Y; Menon M; Trinh QD; Sammon JD; Elder JS
J Pediatr Urol; 2015 Oct; 11(5):246.e1-8. PubMed ID: 26005017
[TBL] [Abstract][Full Text] [Related]
12. Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial.
Rudrabhatla P; Deepanjali S; Mandal J; Swaminathan RP; Kadhiravan T
PLoS One; 2018; 13(5):e0197302. PubMed ID: 29768465
[TBL] [Abstract][Full Text] [Related]
13. Urologic diseases in america project: trends in resource use for urinary tract infections in men.
Griebling TL
J Urol; 2005 Apr; 173(4):1288-94. PubMed ID: 15758784
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
Chang UI; Kim HW; Noh YS; Wie SH
Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
16. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
17. Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial.
Bleidorn J; Hummers-Pradier E; Schmiemann G; Wiese B; Gágyor I
Ger Med Sci; 2016; 14():Doc01. PubMed ID: 26909012
[TBL] [Abstract][Full Text] [Related]
18. Unilateral and bilateral acute pyelonephritis: differences in clinical presentation, progress and outcome.
Lee YJ; Cho S; Kim SR
Postgrad Med J; 2014 Feb; 90(1060):80-5. PubMed ID: 24255118
[TBL] [Abstract][Full Text] [Related]
19. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
Wie SH; Kim HW; Chang UI
Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
[TBL] [Abstract][Full Text] [Related]
20. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection.
Lin KY; Chiu NT; Chen MJ; Lai CH; Huang JJ; Wang YT; Chiou YY
Pediatr Nephrol; 2003 Apr; 18(4):362-5. PubMed ID: 12700963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
